{
    "Question_1": {
        "Context": "Carbon-14 labeling is a technique used to trace molecules and understand their pharmacokinetic profiles. It involves incorporating carbon-14, a radioactive isotope, into the molecule of interest.",
        "Question": "What is the primary application of Carbon-14 (14C) labeling?",
        "A": "Determining the nutritional content of food",
        "B": "Tracing molecules and providing pharmacokinetic profiles",
        "C": "Measuring the age of archaeological artifacts",
        "D": "Enhancing the flavor of processed beverages",
        "Answer": "B",
        "Source": "Carbon\u201114 (14C) labeling is a standard technology for tracing molecules and providing their pharmacokinetic profiles."
    },
    "Question_2": {
        "Context": "In the context of drug development, microdosing is a technique where a very small dose of a drug is administered to gather preliminary pharmacokinetic data.",
        "Question": "What is the purpose of microdosing in drug development?",
        "A": "To cure diseases at minimal doses",
        "B": "To test the maximum tolerated dose of a drug",
        "C": "To gather preliminary pharmacokinetic data",
        "D": "To replace standard clinical trials entirely",
        "Answer": "C",
        "Source": "Microdosing, conducted prior to standard clinical trials, involves administering a smaller dose to the human body."
    },
    "Question_3": {
        "Context": "Reductive amination is a chemical reaction where an aldehyde or ketone reacts with an amine in the presence of a reducing agent to form a new compound.",
        "Question": "What is the role of reductive amination in the context of 14C-labeling of antibodies?",
        "A": "To break down antibody molecules",
        "B": "To visualize antibodies under a microscope",
        "C": "To attach a radioactive isotope to antibodies",
        "D": "To remove impurities from antibody preparations",
        "Answer": "C",
        "Source": "In this report, we present an innovative approach involving antibody labeling with 14C-formaldehyde through reductive amination."
    },
    "Question_4": {
        "Context": "Accelerator mass spectrometry (AMS) is a form of mass spectrometry that accelerates ions to extraordinarily high kinetic energies before mass analysis and is used in microdosing studies for its high sensitivity and accuracy.",
        "Question": "What is a notable advantage of using accelerator mass spectrometry (AMS) in microdosing studies?",
        "A": "It allows for the visualization of drug structures",
        "B": "It reduces the need for clinical trial volunteers",
        "C": "It minimizes the amount of radioactive material administered",
        "D": "It increases the therapeutic dose of the drug",
        "Answer": "C",
        "Source": "AMS, compared to LSC analysis technology, offers high-sensitivity quantification and rapid analysis, providing a notable advantage in significantly minimizing the amount of radioactive material administered during microdosing."
    },
    "Question_5": {
        "Context": "The stability of a labeled compound is crucial for its use in experiments, as it must remain unchanged under storage conditions to provide reliable data.",
        "Question": "Why is the stability of 14C-labeled antibodies important for their use in clinical trials?",
        "A": "To ensure they can be stored indefinitely",
        "B": "To maintain their purity and activity over time",
        "C": "To increase their radioactivity",
        "D": "To make them resistant to high temperatures",
        "Answer": "B",
        "Source": "Stability tests revealed that all groups maintained their purities over a 4\u2011week period at both \u2212 75 \u00b1 10 \u00b0C and 5 \u00b1 3 \u00b0C."
    },
    "Question_6": {
        "Context": "The pharmacokinetic profile of a drug is crucial in understanding how the drug is absorbed, distributed, metabolized, and excreted in the body.",
        "Question": "What aspect of drug behavior does the pharmacokinetic profile of a drug candidate describe?",
        "A": "The drug's color and texture",
        "B": "The drug's taste and solubility",
        "C": "The drug's absorption, distribution, metabolism, and excretion",
        "D": "The drug's packaging and shelf life",
        "Answer": "C",
        "Source": "Radioisotope-labeled compounds are utilized to monitor their biological and physicochemical behaviors by detecting their radioactivity."
    },
    "Question_7": {
        "Context": "Labeling efficiency is a measure of how effectively a label, such as a radioactive isotope, is incorporated into a target molecule or compound.",
        "Question": "What does labeling efficiency indicate in the context of 14C-labeling of antibodies?",
        "A": "The cost of the labeling process",
        "B": "The speed of the labeling reaction",
        "C": "The degree of radioactivity of the label",
        "D": "The proportion of target molecules successfully labeled",
        "Answer": "D",
        "Source": "The reaction with 10 equivalents of reagents demonstrated a labeling efficiency of 1.5 mol/mol."
    },
    "Question_8": {
        "Context": "The specific radioactivity of a labeled compound is defined as the radioactivity per unit mass of the compound.",
        "Question": "What does specific radioactivity measure in a 14C-labeled compound?",
        "A": "The total mass of the compound",
        "B": "The radioactivity per unit mass of the compound",
        "C": "The concentration of the compound in solution",
        "D": "The stability of the compound over time",
        "Answer": "B",
        "Source": "By calculating the specific radioactivity using the protein concentration and the radioactivity concentration, the specific radioactivity of 14C-anti-mouse rabbit IgG was determined."
    },
    "Question_9": {
        "Context": "In the development of new biological entities (NBE), microdosing with a 14C-labeled biomacromolecule can provide early-stage pharmacokinetic data that may lead to time and cost savings.",
        "Question": "What is a benefit of using microdosing with a 14C-labeled biomacromolecule in the development of new biological entities?",
        "A": "It allows for the immediate approval of the drug by regulatory agencies",
        "B": "It provides early-stage pharmacokinetic data that can save time and costs",
        "C": "It eliminates the need for further clinical trials",
        "D": "It guarantees the efficacy of the drug in treating diseases",
        "Answer": "B",
        "Source": "Particularly in the development of new biological entities (NBE), the utilization of microdosing with a 14C\u2011labeled biomacromolecule proves beneficial in the early stages of drug development, contributing to significant time and cost savings."
    },
    "Question_10": {
        "Context": "The use of 14C-formaldehyde in labeling allows for the incorporation of the radioactive isotope into the target molecule through a chemical reaction.",
        "Question": "What is the role of 14C-formaldehyde in the labeling of antibodies?",
        "A": "It acts as a catalyst to speed up the labeling reaction",
        "B": "It serves as a solvent to dissolve the antibodies",
        "C": "It is used as a reducing agent in the labeling process",
        "D": "It is the source of the radioactive isotope in the labeling reaction",
        "Answer": "D",
        "Source": "In this study, the utilization of 14C\u2011formaldehyde for labeling target antibodies at various molar ratios revealed a direct correlation between labeling efficiency and the quantity of 14C\u2011formaldehyde applied."
    }
}